Logo image of CNM

CORE & MAIN INC-CLASS A (CNM) Stock Fundamental Analysis

NYSE:CNM - New York Stock Exchange, Inc. - US21874C1027 - Common Stock - Currency: USD

56.15  +0.54 (+0.97%)

After market: 56.15 0 (0%)

Fundamental Rating

5

Overall CNM gets a fundamental rating of 5 out of 10. We evaluated CNM against 47 industry peers in the Trading Companies & Distributors industry. While CNM belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. CNM is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

CNM had positive earnings in the past year.
In the past year CNM had a positive cash flow from operations.
Each year in the past 5 years CNM has been profitable.
Of the past 5 years CNM 4 years had a positive operating cash flow.
CNM Yearly Net Income VS EBIT VS OCF VS FCFCNM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

1.2 Ratios

CNM has a better Return On Assets (6.63%) than 72.34% of its industry peers.
The Return On Equity of CNM (23.85%) is better than 82.98% of its industry peers.
CNM's Return On Invested Capital of 11.18% is fine compared to the rest of the industry. CNM outperforms 76.60% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CNM is above the industry average of 9.69%.
Industry RankSector Rank
ROA 6.63%
ROE 23.85%
ROIC 11.18%
ROA(3y)7.26%
ROA(5y)5.33%
ROE(3y)23.57%
ROE(5y)17.76%
ROIC(3y)13.05%
ROIC(5y)10.52%
CNM Yearly ROA, ROE, ROICCNM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

CNM's Profit Margin of 5.47% is fine compared to the rest of the industry. CNM outperforms 70.21% of its industry peers.
In the last couple of years the Profit Margin of CNM has grown nicely.
CNM has a Operating Margin of 9.49%. This is in the better half of the industry: CNM outperforms 70.21% of its industry peers.
CNM's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 26.57%, CNM is not doing good in the industry: 61.70% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of CNM has grown nicely.
Industry RankSector Rank
OM 9.49%
PM (TTM) 5.47%
GM 26.57%
OM growth 3Y4.39%
OM growth 5Y16.07%
PM growth 3Y18.52%
PM growth 5Y35.35%
GM growth 3Y1.32%
GM growth 5Y2.7%
CNM Yearly Profit, Operating, Gross MarginsCNM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CNM is creating some value.
The number of shares outstanding for CNM has been reduced compared to 1 year ago.
CNM has less shares outstanding than it did 5 years ago.
CNM has a worse debt/assets ratio than last year.
CNM Yearly Shares OutstandingCNM Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
CNM Yearly Total Debt VS Total AssetsCNM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.2 Solvency

An Altman-Z score of 3.40 indicates that CNM is not in any danger for bankruptcy at the moment.
CNM has a Altman-Z score of 3.40. This is in the better half of the industry: CNM outperforms 63.83% of its industry peers.
The Debt to FCF ratio of CNM is 3.91, which is a good value as it means it would take CNM, 3.91 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CNM (3.91) is comparable to the rest of the industry.
CNM has a Debt/Equity ratio of 1.28. This is a high value indicating a heavy dependency on external financing.
CNM has a Debt to Equity ratio of 1.28. This is in the lower half of the industry: CNM underperforms 70.21% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.28
Debt/FCF 3.91
Altman-Z 3.4
ROIC/WACC1.08
WACC10.36%
CNM Yearly LT Debt VS Equity VS FCFCNM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 1.96 indicates that CNM should not have too much problems paying its short term obligations.
The Current ratio of CNM (1.96) is comparable to the rest of the industry.
CNM has a Quick Ratio of 1.10. This is a normal value and indicates that CNM is financially healthy and should not expect problems in meeting its short term obligations.
CNM has a Quick ratio of 1.10. This is comparable to the rest of the industry: CNM outperforms 42.55% of its industry peers.
Industry RankSector Rank
Current Ratio 1.96
Quick Ratio 1.1
CNM Yearly Current Assets VS Current LiabilitesCNM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

More info and screens

5

3. Growth

3.1 Past

CNM shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.36%.
The Earnings Per Share has been growing by 64.38% on average over the past years. This is a very strong growth
CNM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.80%.
The Revenue has been growing by 17.04% on average over the past years. This is quite good.
EPS 1Y (TTM)-3.36%
EPS 3Y44.94%
EPS 5Y64.38%
EPS Q2Q%0%
Revenue 1Y (TTM)10.8%
Revenue growth 3Y14.14%
Revenue growth 5Y17.04%
Sales Q2Q%9.76%

3.2 Future

CNM is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.00% yearly.
Based on estimates for the next years, CNM will show a small growth in Revenue. The Revenue will grow by 5.27% on average per year.
EPS Next Y7.97%
EPS Next 2Y11.31%
EPS Next 3Y13%
EPS Next 5YN/A
Revenue Next Year4.5%
Revenue Next 2Y4.9%
Revenue Next 3Y5.27%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CNM Yearly Revenue VS EstimatesCNM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B 8B
CNM Yearly EPS VS EstimatesCNM Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 1 2 3

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 24.41, which indicates a rather expensive current valuation of CNM.
The rest of the industry has a similar Price/Earnings ratio as CNM.
When comparing the Price/Earnings ratio of CNM to the average of the S&P500 Index (26.34), we can say CNM is valued inline with the index average.
A Price/Forward Earnings ratio of 19.71 indicates a rather expensive valuation of CNM.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CNM is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.19, CNM is valued at the same level.
Industry RankSector Rank
PE 24.41
Fwd PE 19.71
CNM Price Earnings VS Forward Price EarningsCNM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

CNM's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, CNM is valued a bit cheaper than the industry average as 72.34% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 19.11
EV/EBITDA 14.51
CNM Per share dataCNM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of CNM may justify a higher PE ratio.
A more expensive valuation may be justified as CNM's earnings are expected to grow with 13.00% in the coming years.
PEG (NY)3.06
PEG (5Y)0.38
EPS Next 2Y11.31%
EPS Next 3Y13%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CNM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CORE & MAIN INC-CLASS A

NYSE:CNM (6/18/2025, 8:04:00 PM)

After market: 56.15 0 (0%)

56.15

+0.54 (+0.97%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)06-10 2025-06-10/bmo
Earnings (Next)09-03 2025-09-03/bmo
Inst Owners111.77%
Inst Owner Change4.74%
Ins Owners0.55%
Ins Owner Change0.66%
Market Cap11.07B
Analysts77.78
Price Target61.41 (9.37%)
Short Float %7.87%
Short Ratio7.18
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.68%
Min EPS beat(2)-2.07%
Max EPS beat(2)0.71%
EPS beat(4)2
Avg EPS beat(4)0.29%
Min EPS beat(4)-10.01%
Max EPS beat(4)12.5%
EPS beat(8)6
Avg EPS beat(8)2.7%
EPS beat(12)10
Avg EPS beat(12)8.17%
EPS beat(16)14
Avg EPS beat(16)23.77%
Revenue beat(2)2
Avg Revenue beat(2)1.33%
Min Revenue beat(2)0.41%
Max Revenue beat(2)2.25%
Revenue beat(4)3
Avg Revenue beat(4)-0.33%
Min Revenue beat(4)-5.49%
Max Revenue beat(4)2.25%
Revenue beat(8)4
Avg Revenue beat(8)-0.53%
Revenue beat(12)6
Avg Revenue beat(12)0.87%
Revenue beat(16)10
Avg Revenue beat(16)2.72%
PT rev (1m)0.69%
PT rev (3m)-1.52%
EPS NQ rev (1m)0.47%
EPS NQ rev (3m)4.63%
EPS NY rev (1m)0%
EPS NY rev (3m)0.46%
Revenue NQ rev (1m)0.52%
Revenue NQ rev (3m)1.62%
Revenue NY rev (1m)0.61%
Revenue NY rev (3m)0.05%
Valuation
Industry RankSector Rank
PE 24.41
Fwd PE 19.71
P/S 1.45
P/FCF 19.11
P/OCF 17.85
P/B 6.35
P/tB N/A
EV/EBITDA 14.51
EPS(TTM)2.3
EY4.1%
EPS(NY)2.85
Fwd EY5.07%
FCF(TTM)2.94
FCFY5.23%
OCF(TTM)3.15
OCFY5.6%
SpS38.61
BVpS8.85
TBVpS-5.36
PEG (NY)3.06
PEG (5Y)0.38
Profitability
Industry RankSector Rank
ROA 6.63%
ROE 23.85%
ROCE 14.35%
ROIC 11.18%
ROICexc 11.19%
ROICexgc 25.29%
OM 9.49%
PM (TTM) 5.47%
GM 26.57%
FCFM 7.61%
ROA(3y)7.26%
ROA(5y)5.33%
ROE(3y)23.57%
ROE(5y)17.76%
ROIC(3y)13.05%
ROIC(5y)10.52%
ROICexc(3y)13.27%
ROICexc(5y)10.76%
ROICexgc(3y)30.58%
ROICexgc(5y)28.28%
ROCE(3y)16.76%
ROCE(5y)13.51%
ROICexcg growth 3Y-1.87%
ROICexcg growth 5Y6.48%
ROICexc growth 3Y6.77%
ROICexc growth 5Y19.1%
OM growth 3Y4.39%
OM growth 5Y16.07%
PM growth 3Y18.52%
PM growth 5Y35.35%
GM growth 3Y1.32%
GM growth 5Y2.7%
F-Score6
Asset Turnover1.21
Health
Industry RankSector Rank
Debt/Equity 1.28
Debt/FCF 3.91
Debt/EBITDA 2.44
Cap/Depr 20.92%
Cap/Sales 0.54%
Interest Coverage 4.08
Cash Conversion 67.54%
Profit Quality 139.18%
Current Ratio 1.96
Quick Ratio 1.1
Altman-Z 3.4
F-Score6
WACC10.36%
ROIC/WACC1.08
Cap/Depr(3y)20.09%
Cap/Depr(5y)16.28%
Cap/Sales(3y)0.48%
Cap/Sales(5y)0.43%
Profit Quality(3y)174.31%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3.36%
EPS 3Y44.94%
EPS 5Y64.38%
EPS Q2Q%0%
EPS Next Y7.97%
EPS Next 2Y11.31%
EPS Next 3Y13%
EPS Next 5YN/A
Revenue 1Y (TTM)10.8%
Revenue growth 3Y14.14%
Revenue growth 5Y17.04%
Sales Q2Q%9.76%
Revenue Next Year4.5%
Revenue Next 2Y4.9%
Revenue Next 3Y5.27%
Revenue Next 5YN/A
EBIT growth 1Y-1.23%
EBIT growth 3Y19.16%
EBIT growth 5Y35.85%
EBIT Next Year33.49%
EBIT Next 3Y15.45%
EBIT Next 5YN/A
FCF growth 1Y9.45%
FCF growth 3YN/A
FCF growth 5Y24.92%
OCF growth 1Y11.11%
OCF growth 3YN/A
OCF growth 5Y24.63%